Results 171 to 180 of about 12,522,600 (400)
Pemanfaatan Aplikasi Sistem Pakar Untuk Diagnosa Penyakit Paru-paru [PDF]
, 2011 Expert system to diagnose lung disease was designed as a tool to diagnose the type of lung disease in particular. The knowledge obtained from various sources such as research and exposure to experts in the field and conducted a book-related lung disease.
Irianto, S. Y. (Suhendro) +1 more
core
Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology
Molecular Oncology, EarlyView.Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts +8 more
wiley +1 more source
Lung Cancer and Interstitial Lung Diseases
CancersLung cancer continues to be one of the leading causes of cancer-related death worldwide. There is evidence of a complex interplay between lung cancer and interstitial lung disease (ILD), affecting disease progression, management strategies, and patient outcomes. Both conditions develop as the result of common risk factors such as smoking, environmental
Fotios Drakopanagiotakis +6 more
openaire +2 more sources
Molecular Oncology, EarlyView.A‐to‐I editing of miRNAs, particularly miR‐200b‐3p, contributes to HGSOC progression by enhancing cancer cell proliferation, migration and 3D growth. The edited form is linked to poorer patient survival and the identification of novel molecular targets.
Magdalena Niemira +14 more
wiley +1 more source
Bicaudal D1 impairs autophagosome maturation in chronic obstructive pulmonary disease
FASEB BioAdvances, 2019 Bicaudal D1 (BICD1), an adaptor for the dynein‐dynactin motor complex, has been identified as a susceptibility gene in chronic obstructive pulmonary disease (COPD).
Nicolas Mercado +8 more
doaj +1 more source
Geographical Distribution of Disease: With Special Reference to Cancer of the Lung and Stomach in Wales [PDF]
, 1959 G. Melvyn Howe
openalex +1 more source
Molecular Oncology, EarlyView.This real‐world study of ROS1+ NSCLC highlights fusion diversity, treatment outcomes with crizotinib and lorlatinib, and in vitro experiments with resistance mechanisms. G2032R drives strong resistance to ROS1‐targeted TKIs, especially lorlatinib. Fusion partner location does not affect overall survival to crizotinib or lorlatinib. Findings support the
Fenneke Zwierenga +8 more
wiley +1 more source
Pneumoconiosis: Industrial Diseases of the Lung Caused by Dust [PDF]
, 1958 A. Meiklejohn
openalex +1 more source
Molecular Oncology, EarlyView.We investigated whether hypomethylating agents (HMAs) used in myeloid malignancies induce somatic retrotransposition. Our findings indicate that HMA treatment increases L1‐encoded protein expression but does not lead to detectable de novo retrotransposition events in either patient samples or cell lines.
Šárka Pavlová +14 more
wiley +1 more source